472611

(1,3-Dioxolan-2-ylmethyl)magnesiumbromid -Lösung

0.5 M in THF

• Synonym(e): 2-[(Bromomagnesio)methyl]-1,3-dioxolane, Bromo(1,3-dioxolan-2-ylmethyl)magnesium
• Empirische Formel (Hill-System): C₄H₇BrMgO₂
• CAS-Nummer: 180675-22-3
• Molekulargewicht: 191.31
• MDL-Nummer: MFCD01321271
• UNSPSC-Code: 12352103
• PubChem Substanz-ID: 24870813
• NACRES: NA.22

Eigenschaften

• Eignung der Reaktion: reaction type: Grignard Reaction
• Qualitätsniveau: 100
• Konzentration: 0.5 M in THF
• bp: 65-67 °C
• Dichte: 0.938 g/mL at 25 °C
• Funktionelle Gruppe: ether
• SMILES String: Br[Mg]CC1OCCO1
• InChI: 1S/C4H7O2.BrH.Mg/c1-4-5-2-3-6-4;;/h4H,1-3H2;1H;/q;;+1/p-1
• InChIKey: ZDNTZRAFJZERSL-UHFFFAOYSA-M

Beschreibung

Anwendung

(1,3-Dioxolan-2-ylmethyl)magnesium bromide is a Grignard reagent that can be used to prepare:

• 3-[¹¹C]-Propionaldehyde, a key intermediate for the synthesis of radiolabeled compound [¹¹C]SN-38, wherein SN-38 is 7-ethyl-10-hydroxy camptothecin.
• 1-[(S)-2,2-Dimethyl-(1,3)-dioxolan-4-yl]-4-(1,3-dioxolan2-yl)-2-ol by reacting with D-glyceraldehyde, which is further used to synthesize unsaturated nucleosides.
• A bicyclo carboxylate intermediate, which is employed in the total synthesis of spirovibsanin A.

Sicherheitshinweise

• Piktogramme: GHS02,GHS08,GHS05,GHS07
• Signalwort: Danger
• H-Sätze: H225,H302,H314,H335,H336,H351
• P-Sätze: P201 - P210 - P280 - P303 + P361 + P353 - P305 + P351 + P338 + P310 - P308 + P313
• Gefahreneinstufungen: Acute Tox. 4 Oral - Carc. 2 - Eye Dam. 1 - Flam. Liq. 2 - Skin Corr. 1B - STOT SE 3
• Zielorgane: Central nervous system, Respiratory system
• Zusätzliche Gefahrenhinweise: EUH018,EUH019
• Lagerklassenschlüssel: 3 - Flammable liquids
• WGK: WGK 3
• Flammpunkt (°F): 1.4 °F - closed cup
• Flammpunkt (°C): -17 °C - closed cup
• Persönliche Schutzausrüstung: Faceshields, Gloves, Goggles, type ABEK (EN14387) respirator filter